Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novoHodgkin lymphoma
Open Access
- 10 January 2015
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 90 (4), 334-338
- https://doi.org/10.1002/ajh.23939
Abstract
Although transformation to Hodgkin lymphoma (HL) is a recognized complication in patients with chronic lymphocytic leukemia (CLL), its incidence, clinical characteristics and outcomes are not well defined. We used the Mayo Clinic CLL and Lymphoma Databases to identify CLL patients who developed biopsy‐proven HL (CLL/HL) on follow‐up, as well as cases of de novo HL (i.e., without prior CLL). Among 3887 CLL patients seen at Mayo Clinic from January 1995 through August 2011, 26 (0.7%) developed HL. In a nested cohort of 2,465 newly diagnosed CLL patients followed prospectively, the incidence of HL was 0.05%/year (10 year risk = 0.5%). The median overall survival (OS) from date of HL diagnosis in patients with CLL/HL was 3.9 years compared to not reached for de novo HL patients (n = 709) seen during the same time interval (P < 0.001). The shorter OS of CLL/HL patients persisted after adjusting for differences in age and Ann Arbor stage of disease. The International Prognostic score (IPS) developed for de novo HL stratified prognosis among CLL/HL patients with median survival of not reached, 6.2, 2.4, and 0.3 years (P = 0.006) for those with IPS scores of ≤2, 3, 4, and ≥5, respectively. In summary, approximately 1 of every 200 CLL patients will develop HL within 10 years. Survival after HL diagnosis in patients with CLL is shorter than de novo HL patients. The IPS for de novo HL may be useful for stratifying survival in CLL/HL patients. Am. J. Hematol. 90:334–338, 2015.Funding Information
- NCI (K23CA160345, CA95241)
- Predolin Foundation
This publication has 32 references indexed in Scilit:
- Diffuse large B‐cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patientsBritish Journal of Haematology, 2013
- XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomesHematological Oncology, 2013
- Poor prognosis of Hodgkin variant of Richter transformation in chronic lymphocytic leukemia treated with cladribineBritish Journal of Haematology, 2012
- EBV-associated lymphomas in adultsBest Practice & Research Clinical Haematology, 2012
- Clonally identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLLBone Marrow Transplantation, 2011
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive LymphomasThe New England Journal of Medicine, 2010
- Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemiaCancer, 2010
- Hodgkin’s disease variant of Richter’s syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLLMedical Hypotheses, 2006
- Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell TransplantationJournal of Clinical Oncology, 2006
- A Prognostic Score for Advanced Hodgkin's DiseaseThe New England Journal of Medicine, 1998